Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	DUF3585	MICAL3 EHBP1L1	7.97e-05	7	37	2	PF12130
Domain	DUF3585	MICAL3 EHBP1L1	7.97e-05	7	37	2	IPR022735
Domain	p53-like_TF_DNA-bd	EOMES RUNX3 NFAT5	1.57e-04	53	37	3	IPR008967
Domain	CH	NAV2 MICAL3 EHBP1L1	2.87e-04	65	37	3	SM00033
Domain	CH	NAV2 MICAL3 EHBP1L1	3.58e-04	70	37	3	PF00307
Domain	-	NAV2 MICAL3 EHBP1L1	3.73e-04	71	37	3	1.10.418.10
Domain	CH	NAV2 MICAL3 EHBP1L1	4.05e-04	73	37	3	PS50021
Domain	CH-domain	NAV2 MICAL3 EHBP1L1	4.38e-04	75	37	3	IPR001715
Domain	DEAD_ATP_HELICASE	DDX4 EIF4A1	1.71e-03	31	37	2	PS00039
Domain	RNA-helicase_DEAD-box_CS	DDX4 EIF4A1	1.94e-03	33	37	2	IPR000629
Domain	RNA_helicase_DEAD_Q_motif	DDX4 EIF4A1	2.43e-03	37	37	2	IPR014014
Domain	Q_MOTIF	DDX4 EIF4A1	2.43e-03	37	37	2	PS51195
Domain	DEAD	DDX4 EIF4A1	9.19e-03	73	37	2	PF00270
Domain	DEAD/DEAH_box_helicase_dom	DDX4 EIF4A1	9.19e-03	73	37	2	IPR011545
Domain	Helicase_C	DDX4 EIF4A1	1.90e-02	107	37	2	PF00271
Domain	HELICc	DDX4 EIF4A1	1.90e-02	107	37	2	SM00490
Domain	Helicase_C	DDX4 EIF4A1	1.93e-02	108	37	2	IPR001650
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MICAL3 RNF169 CTIF KAZN PLEKHG3 PALLD	1.26e-05	493	37	6	15368895
Pubmed	Rac1 modulates the formation of primordial follicles by facilitating STAT3-directed Jagged1, GDF9 and BMP15 transcription in mice.	DDX4 BMP15	1.65e-05	6	37	2	27050391
Pubmed	A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells.	EOMES RUNX3	1.65e-05	6	37	2	25129370
Pubmed	The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma.	EOMES RUNX3	3.07e-05	8	37	2	20399120
Pubmed	Single-cell transcriptome landscape of ovarian cells during primordial follicle assembly in mice.	DDX4 EIF4A1	3.07e-05	8	37	2	33351795
Pubmed	The N-terminal BRCT domain determines MCPH1 function in brain development and fertility.	EOMES DDX4	3.07e-05	8	37	2	33542216
Pubmed	Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates.	EOMES CELF2	3.95e-05	9	37	2	34107259
Pubmed	Biasing the conformation of ELMO2 reveals that myoblast fusion can be exploited to improve muscle regeneration.	MYOD1 ELMO1	7.22e-05	12	37	2	36400788
Pubmed	Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline.	EOMES DDX4	7.22e-05	12	37	2	20823249
Pubmed	Compromised cell competition exhausts neural stem cells pool.	EOMES ELMO1	8.53e-05	13	37	2	39010274
Pubmed	Three-dimensional molecular architecture of mouse organogenesis.	EOMES CELF2 DDX4	1.67e-04	100	37	3	37524711
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NAV2 RNF169 ZNF148 TRIM29 PALLD	1.85e-04	503	37	5	16964243
Pubmed	RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2.	RUNX3 DDX4	2.28e-04	21	37	2	31712577
Pubmed	Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.	EHBP1L1 PALLD	2.28e-04	21	37	2	20708005
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	KAZN ZNF148 NFAT5 CAVIN2 EIF4A1 U2SURP	2.50e-04	847	37	6	35850772
Pubmed	Primary cilia function regulates the length of the embryonic trunk axis and urogenital field in mice.	MYOD1 DDX4	2.51e-04	22	37	2	25224227
Pubmed	Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon.	EOMES OPRM1	2.51e-04	22	37	2	11124115
Pubmed	A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.	FCHSD2 RUNX3	2.51e-04	22	37	2	23266558
Pubmed	Gene network analysis in a pediatric cohort identifies novel lung function genes.	MICAL3 CTIF	2.99e-04	24	37	2	24023788
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	KIAA1549 NFAT5 U2SURP	3.61e-04	130	37	3	12421765
Pubmed	A census of human transcription factors: function, expression and evolution.	EOMES KIAA1549 ZNF148 RUNX3 NFAT5 MYOD1	3.63e-04	908	37	6	19274049
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	ZNF148 RUNX3 NFAT5 EIF4A1 U2SURP	3.64e-04	583	37	5	29844126
Pubmed	Proteomic analysis of FOXP proteins reveals interactions between cortical transcription factors associated with neurodevelopmental disorders.	ZNF148 NFAT5	4.09e-04	28	37	2	29365100
Pubmed	Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.	EOMES DDX4	4.09e-04	28	37	2	23473982
Pubmed	Tagging genes with cassette-exchange sites.	NAV2 CLASP2 RNF169 ZNF148	4.35e-04	335	37	4	15741177
Pubmed	ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles.	DDX4 BMP15	5.02e-04	31	37	2	31657143
Pubmed	The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency.	EOMES DDX4	6.05e-04	34	37	2	20007774
Pubmed	Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex.	CELF2 EIF4A1	6.41e-04	35	37	2	37758766
Pubmed	Charting the landscape of tandem BRCT domain-mediated protein interactions.	MICAL3 CLASP2 PALLD EIF4A1 U2SURP	6.84e-04	670	37	5	22990118
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	EOMES CLASP2	7.16e-04	37	37	2	27565344
Pubmed	WDR62 is required for centriole duplication in spermatogenesis and manchette removal in spermiogenesis.	EOMES DDX4	7.56e-04	38	37	2	34059773
Pubmed	Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation.	EOMES MYOD1	8.80e-04	41	37	2	22147266
Pubmed	SOX4 regulates gonad morphogenesis and promotes male germ cell differentiation in mice.	MYOD1 DDX4	8.80e-04	41	37	2	28118982
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	RNF169 PALLD U2SURP	9.92e-04	184	37	3	32908313
Cytoband	11q13.4	FCHSD2 RNF169	1.69e-03	75	37	2	11q13.4
GeneFamily	DEAD-box helicases	DDX4 EIF4A1	1.41e-03	42	24	2	499
Coexpression	GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN	CLASP2 PALLD DDX4 ELMO1 U2SURP	8.58e-06	199	37	5	M3716
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MICAL3 RUNX3 CELF2 PALLD ELMO1	2.40e-07	164	37	5	519ab4fe885dfe4c50846f346a062acc2cb44299
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAV2 NFKBIZ TNFAIP8L3 PALLD	9.51e-06	161	37	4	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B2\|367C / Donor, Lineage, Cell class and subclass (all cells)	EOMES RUNX3 PLEKHG3 OPRM1	9.75e-06	162	37	4	59c0dcb5b51c1803660aeec51b60deceeeaeea66
ToppCell	T_cells-GNLY+GZMB+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ZC2HC1C RUNX3 PLEKHG3 PALLD	1.21e-05	171	37	4	04c811817cfec45af5f2891793106cc7ddb0300e
ToppCell	COVID-matDC-\|COVID / Condition, Cell_class and T cell subcluster	NAV2 KAZN TNFAIP8L3 CAVIN2	1.32e-05	175	37	4	db5e170411dfa62074c4b8311bb8c589d1c4279b
ToppCell	COVID-matDC\|COVID / Condition, Cell_class and T cell subcluster	NAV2 KAZN TNFAIP8L3 CAVIN2	1.32e-05	175	37	4	e2b638109c9ffd10430e6e134035622b7605ce23
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARD6 CFAP54 TNFAIP8L3 CAVIN2	1.54e-05	182	37	4	8d8f28bd43108b2fb3a6c2a3d77a897853d440a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CTIF CFAP54 KAZN PALLD	1.64e-05	185	37	4	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	P03\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAV2 NFKBIZ CELF2 PALLD	1.64e-05	185	37	4	a07dbe1f76e40734a28826423a5cc64b8e56af5e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CTIF CFAP54 KAZN PALLD	1.64e-05	185	37	4	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	LAM-Epithelial-AT1\|Epithelial / Condition, Lineage and Cell class	SLC5A5 NAV2 PALLD CAVIN2	1.86e-05	191	37	4	3457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NAV2 MICAL3 CELF2 PALLD	1.90e-05	192	37	4	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FCHSD2 CELF2 NFAT5 ELMO1	1.94e-05	193	37	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2 ELMO1	1.94e-05	193	37	4	12f1333f11e6c262954ad7912d8fd2962ab06d25
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MICAL3 KAZN PALLD ELMO1	1.98e-05	194	37	4	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2 ELMO1	1.98e-05	194	37	4	633fe72cc8a489abde12428e326478409ca03263
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2 ELMO1	1.98e-05	194	37	4	87a86df0b542f287b0b20f4a4b1a37002271671d
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	NAV2 NFKBIZ KAZN CELF2	2.02e-05	195	37	4	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	NAV2 FCHSD2 EHBP1L1 TNFAIP8L3	2.02e-05	195	37	4	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	NAV2 NFKBIZ KAZN CELF2	2.06e-05	196	37	4	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 RUNX3 CELF2 ELMO1	2.10e-05	197	37	4	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 RUNX3 CELF2 ELMO1	2.10e-05	197	37	4	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FCHSD2 MICAL3 CFAP54 ELMO1	2.10e-05	197	37	4	0f489d26e4013d1b5a90559856ed2de32a0bb772
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 NFKBIZ PALLD CAVIN2	2.14e-05	198	37	4	920d2e6603a06c2e8dcb6be127202d222c662bca
ToppCell	3'_v3-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 NFKBIZ PALLD CAVIN2	2.14e-05	198	37	4	807e3ed34739eca159dd0970f884b073e588c649
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EOMES RUNX3 CELF2 OPRM1	2.19e-05	199	37	4	09e0b45529fa9d5fc86da1747b3fb3a238a09aa6
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	EOMES RUNX3 PLEKHG3 PALLD	2.19e-05	199	37	4	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	EOMES RUNX3 PLEKHG3 PALLD	2.19e-05	199	37	4	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	EOMES RUNX3 PLEKHG3 PALLD	2.19e-05	199	37	4	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	EOMES RUNX3 PLEKHG3 PALLD	2.19e-05	199	37	4	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	EOMES RUNX3 PLEKHG3 PALLD	2.23e-05	200	37	4	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EOMES RUNX3 CELF2 OPRM1	2.23e-05	200	37	4	13d8c5d65d7f900979319433e7044efa6d06de20
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Nnat_(Presubiculum,_Col5a2+)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	XKR7 ITPRID1 MYOD1	2.82e-05	71	37	3	3f7ab70a5451043019f6e56c16ab95182ff44a15
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Nnat_(Presubiculum,_Col5a2+)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	XKR7 ITPRID1 MYOD1	2.82e-05	71	37	3	f0af76191cb0e29abf6e7d1a6f5a0df1ad837ce7
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EOMES RUNX3 DDX4	2.21e-04	142	37	3	c2a3cd9998fd9a8e6b2665347ca5c32511776488
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EOMES RUNX3 DDX4	2.35e-04	145	37	3	23a1ee986774725a9f5a9154fbbd023031fb0452
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	XKR7 C16orf90 MYOD1	2.40e-04	146	37	3	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EOMES RUNX3 OPRM1	2.55e-04	149	37	3	f4bee5fdaaa4a1917e403de90e5a62353006df24
ToppCell	368C-Myeloid-Mast_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	KIAA1549 NFKBIZ CFAP54	2.70e-04	152	37	3	faf30245a1690aaa27c7be0832797c340e4af4d7
ToppCell	368C-Myeloid-Mast_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	KIAA1549 NFKBIZ CFAP54	2.70e-04	152	37	3	519c9ed05fdaf420e42147ffae1dc05a7f86fdd4
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RUNX3 CELF2	2.97e-04	157	37	3	170197b76620df31495f1247f365da382b2d8045
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RUNX3 CARF	2.97e-04	157	37	3	a633fb8e7a009490c6002bf272eceaf317f27af6
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RUNX3 CELF2	2.97e-04	157	37	3	c21520301cc0d5d4b1cc4b8ec735f9adb698e768
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RUNX3 CELF2	3.02e-04	158	37	3	7274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	KIAA1549 MICAL3 CTIF	3.02e-04	158	37	3	74aa4f75307575ac3b2b1aa9f727753692f88742
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC5A5 CTIF MYOD1	3.02e-04	158	37	3	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC5A5 CTIF MYOD1	3.02e-04	158	37	3	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	COVID-19_Severe-NK_CD56bright\|COVID-19_Severe / disease group, cell group and cell class	EOMES RUNX3 PLEKHG3	3.08e-04	159	37	3	9e2067f0d76769717f7048dab505fadd36bbb83e
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	TNFAIP8L3 RUNX3 CAVIN2	3.14e-04	160	37	3	8aaf6ac4f33ea291387fdbf9ff1a91d559391774
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B\|367C / Donor, Lineage, Cell class and subclass (all cells)	EOMES RUNX3 PLEKHG3	3.20e-04	161	37	3	f7dc1e3326ab22f2eb1e94b632469a0682a3289c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 EHBP1L1 PALLD	3.37e-04	164	37	3	b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	EOMES RUNX3 PLEKHG3	3.37e-04	164	37	3	84a1808bc6f501218ac2a5a05eb188a07ccd3890
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	NAV2 FCHSD2 MICAL3	3.43e-04	165	37	3	8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EHBP1L1 RUNX3 CARF	3.43e-04	165	37	3	1c630f9ecde2e0243922a2be4b1ab5adcfcb0893
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	FCHSD2 MICAL3 ELMO1	3.62e-04	168	37	3	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	3.62e-04	168	37	3	318fa1bd5a9d6ae95042517ef30515b6416b61e4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	3.62e-04	168	37	3	75b3998aff704a77895ee3723813d8a3819b7cec
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MICAL3 CFAP54 KAZN	3.62e-04	168	37	3	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	RA-01._Fibroblast_I\|RA / Chamber and Cluster_Paper	NAV2 KAZN CELF2	3.68e-04	169	37	3	6373562ab3b1765060212a6a53d6543e7e942e80
ToppCell	droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHBP1L1 RUNX3 CARF	3.75e-04	170	37	3	545c755b057871b7a22221a049a63a61713dad1d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 KAZN PALLD	3.81e-04	171	37	3	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 KAZN PALLD	3.81e-04	171	37	3	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	C16orf90 TP53AIP1 TRIM29	3.88e-04	172	37	3	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EOMES RUNX3 OPRM1	3.88e-04	172	37	3	2b0333c21b7472194a7b9feb3de121da3340fc5b
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC5A5 CFAP54 PLEKHG3	3.94e-04	173	37	3	d78397e65e997ddb995111a810f0e2a4f67d0765
ToppCell	facs-Trachea-nan-24m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP54 C16orf90 DDX4	3.94e-04	173	37	3	27ae126c720f20d1fe116abbcd358e4cff8baf6b
ToppCell	facs-Heart-LV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC5A5 CFAP54 PLEKHG3	3.94e-04	173	37	3	3c852ffe22f4a5b632463086b08c669310684e80
ToppCell	droplet-Mammary_Gland-nan-3m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MICAL3 NFAT5 CAVIN2	3.94e-04	173	37	3	fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 PALLD CAVIN2	4.01e-04	174	37	3	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	NAV2 PALLD ELMO1	4.01e-04	174	37	3	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	KIAA1549 PALLD CAVIN2	4.01e-04	174	37	3	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.01e-04	174	37	3	47e308a777c927ae69ed344cb3dd8561bf2c48a5
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.01e-04	174	37	3	a92c745d20633909db0f08effa13fc738fda79a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 KAZN TNFAIP8L3	4.08e-04	175	37	3	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIAA1549 FCHSD2 C16orf90	4.08e-04	175	37	3	aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.08e-04	175	37	3	2f43883d7c89f09b0579a390a7431f1f9b832582
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NAV2 KAZN TNFAIP8L3	4.08e-04	175	37	3	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.08e-04	175	37	3	da92eb8af0c7c65fed4a1d960708240f35dd997d
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NFKBIZ RNF169 PALLD	4.08e-04	175	37	3	cf53a15bfb37b6019e7052ffdf594a9ac040900e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 CELF2 ELMO1	4.22e-04	177	37	3	b07e6139618d888a9fd7cf43cad0d86a3f63e09e
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5\|TCGA-Lung / Sample_Type by Project: Shred V9	TP53AIP1 TRIM29 PLEKHG3	4.22e-04	177	37	3	a0c7d08469c513cecf87777c19876884f1511570
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RUNX3 DDX4 OPRM1	4.22e-04	177	37	3	89e9ac601bc80bd33141da84056189950e563a1e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 CELF2 ELMO1	4.22e-04	177	37	3	6376ec12322c04d5d37ec2fdc376700464cbc7fb
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 CELF2 ELMO1	4.29e-04	178	37	3	24e8c62060455159235985f456af0c5023a7f3f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 CELF2 ELMO1	4.29e-04	178	37	3	4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell	LA-17._Lymphocyte\|World / Chamber and Cluster_Paper	KIAA1549 RUNX3 ELMO1	4.29e-04	178	37	3	34ec499d03cc198cfefa19a724d4c81974052f65
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MICAL3 CFAP54 KAZN	4.29e-04	178	37	3	544379f5a6145429762258d426b876bb36c112f5
ToppCell	facs\|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 TRIM29 PALLD	4.36e-04	179	37	3	8001db3044e8657980e24422377c4fdb0d7b323e
ToppCell	normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|normal_Lymph_Node / Location, Cell class and cell subclass	EOMES KAZN RUNX3	4.36e-04	179	37	3	3dc929a10381b7d86650c6cd8f354892fe1d93e7
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-NK_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAV2 XKR7 RUNX3	4.36e-04	179	37	3	6f657c7a227f860934d0dfec9b97d35fd2cedfd2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.43e-04	180	37	3	bb2dbf7ed03d5ac765635b7afe738efa822841d0
ToppCell	COVID-19-kidney-Bcells\|kidney / Disease (COVID-19 only), tissue and cell type	FCHSD2 CELF2 ELMO1	4.43e-04	180	37	3	5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	NFKBIZ PALLD CAVIN2	4.43e-04	180	37	3	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 CELF2 ELMO1	4.43e-04	180	37	3	65c069585737302a69b9a01476f4eb8b50cb2bfd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EOMES RUNX3 CELF2	4.43e-04	180	37	3	c62417f205bcbf3b212ae177f63562ec6467c855
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	NAV2 KAZN CELF2	4.50e-04	181	37	3	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	EOMES RUNX3 TRIM29	4.50e-04	181	37	3	9c4f9abb9335da2b07644bca8faff1baa1bb9f5b
ToppCell	normal_Lymph_Node-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	EOMES KAZN RUNX3	4.50e-04	181	37	3	7e12030965881b023f0d3d27d934fa648e2cc523
ToppCell	COVID-19-kidney-Mito-rich_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	RUNX3 CELF2 ELMO1	4.50e-04	181	37	3	8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FCHSD2 RUNX3 ELMO1	4.50e-04	181	37	3	5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659
Drug	Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A	LMF1 EHBP1L1 KAZN TRIM29 PLEKHG3	1.53e-05	195	37	5	6808_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CTIF LMF1 KAZN NFAT5 PLEKHG3	1.53e-05	195	37	5	2234_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SLC5A5 ZC2HC1C CTIF EHBP1L1 OPRM1	1.60e-05	197	37	5	5242_UP
Drug	prednisolone; Up 200; 1uM; MCF7; HG-U133A	CLASP2 CTIF LMF1 NFAT5 PLEKHG3	1.68e-05	199	37	5	265_UP
Drug	levo-dromoran tartrate	TNFAIP8L3 DDX4 CAVIN2 OPRM1	1.91e-05	98	37	4	CID000003918
Drug	nalorphine-epoxide	DDX4 OPRM1	2.56e-05	5	37	2	CID003086440
Disease	carotid artery intima media thickness	NAV2 CTIF KAZN PALLD MYOD1 ELMO1	1.90e-05	450	37	6	EFO_0007117
Disease	adverse effect, response to xenobiotic stimulus	NAV2 RUNX3 CELF2	5.62e-05	59	37	3	EFO_0009658, GO_0009410
Disease	psoriasis vulgaris	NFKBIZ RUNX3 ELMO1	6.21e-05	61	37	3	EFO_1001494
Disease	response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent	KAZN ELMO1	1.00e-04	12	37	2	GO_0097327, GO_0097328, MONDO_0009354
Disease	Gastro-enteropancreatic neuroendocrine tumor	EOMES RUNX3	1.59e-04	15	37	2	C2930967
Disease	Toxic Epidermal Necrolysis	CELF2 ELMO1	6.08e-04	29	37	2	C0014518
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	CELF2 ELMO1	6.08e-04	29	37	2	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	CELF2 ELMO1	6.08e-04	29	37	2	C3658302
Disease	Drug-Induced Stevens Johnson Syndrome	CELF2 ELMO1	6.08e-04	29	37	2	C1274933
Disease	Stevens-Johnson Syndrome	CELF2 ELMO1	6.51e-04	30	37	2	C0038325
Disease	shoulder impingement syndrome	CELF2 ELMO1	9.38e-04	36	37	2	EFO_1001178
Disease	cholesteryl ester 18:3 measurement	NAV2 ELMO1	1.16e-03	40	37	2	EFO_0010346
Disease	urinary albumin to creatinine ratio	KAZN TRIM29 CELF2	1.47e-03	179	37	3	EFO_0007778
Disease	multiple sclerosis symptom measurement	CTIF ITPRID1	1.53e-03	46	37	2	EFO_0803536
Disease	total blood protein measurement	EOMES MICAL3 EHBP1L1 RUNX3	2.35e-03	449	37	4	EFO_0004536
Disease	blood osmolality measurement	NAV2 NFAT5	2.42e-03	58	37	2	EFO_0007967
Disease	Malignant Glioma	SLC5A5 TRIM29	3.50e-03	70	37	2	C0555198
Disease	mixed gliomas	SLC5A5 TRIM29	3.50e-03	70	37	2	C0259783
Disease	nephrotic syndrome	RUNX3 ELMO1	3.60e-03	71	37	2	EFO_0004255
Disease	albumin:globulin ratio measurement	FCHSD2 RUNX3	3.80e-03	73	37	2	EFO_0005128
Disease	psoriasis, type 2 diabetes mellitus	NFKBIZ RUNX3	4.01e-03	75	37	2	EFO_0000676, MONDO_0005148
Disease	Hodgkins lymphoma	EOMES MYOD1	4.77e-03	82	37	2	EFO_0000183
Disease	psoriasis	ITPRID1 RUNX3 ELMO1	4.82e-03	273	37	3	EFO_0000676
Disease	thalamus volume	NAV2 NFAT5	5.12e-03	85	37	2	EFO_0006935
Disease	psoriatic arthritis	NFKBIZ RUNX3	5.35e-03	87	37	2	EFO_0003778
Disease	Glioma	SLC5A5 TRIM29	5.35e-03	87	37	2	C0017638
Disease	ankylosing spondylitis	EOMES RUNX3	5.84e-03	91	37	2	EFO_0003898
Disease	serum albumin measurement	MICAL3 EHBP1L1 ZNF148 EIF4A1	6.27e-03	592	37	4	EFO_0004535

Protein segments in the cluster

Peptide	Gene	Start	Entry
ASAGAPAAMLSDTDA	EOMES	71	O95936
ASTPNSTAGAAMNSL	CELF2	321	O95319
MAAQGSPSSSPSDDS	CFAP54	1	Q96N23
AFDAESEPNNSSGSM	ELMO1	331	Q92556
MENSSAASASSEAGS	CTIF	1	O43310
GDNFNRTPASSSEMD	DDX4	31	Q9NQI0
MGDAASQSPPESSAA	KIAA1549	901	Q9HCM3
MDSSAAPTNASNCTD	OPRM1	1	P35372
EERMAPASESSASGA	MICAL3	1051	Q7RTP6
ASAAGDSAATNMENP	KAZN	56	Q674X7
ASDSSNTSLPFSNMG	NFKBIZ	391	Q9BYH8
ESDGPDSKSRASMSF	ITPRID1	471	Q6ZRS4
SSEGDSSKPSLMSNA	BMP15	166	O95972
MDSRDSSFGQNDSPT	CARF	31	Q8N187
MSASQDSRSRDNGPD	EIF4A1	1	P60842
DSDASSPRSNCSDGM	MYOD1	196	P15172
RNSSSFSMDDPDAGA	EHBP1L1	1291	Q8N3D4
ADASSAPSSSSMGGA	NFAT5	66	O94916
ASRSAPAMQSSGSFN	PALLD	716	Q8WX93
QSMGASSNSEDAFSP	CARD6	106	Q9BX69
PRDSLGSSASSSSMD	C16orf90	126	A8MZG2
DNMDVFDDSSSSPSG	FCHSD2	451	O94868
AEKATSRGSNSGMDS	CAVIN2	356	O95810
SSAASVAAGNLMNPS	RUNX3	366	Q13761
MEAADASRSNGSSPE	TRIM29	1	Q14134
MGSSSEASFRSAQAS	TP53AIP1	1	Q9HCN2
SGSSCDSRSAMEEPS	PLEKHG3	26	A1L390
MSDNAPASLESGSSS	NAV2	346	Q8IVL1
MAAAGPSTRASSAAA	RNF169	1	Q8NCN4
SSDAHMDASGPSDSD	U2SURP	26	O15042
MSDPRAGGDATDSSQ	CLASP2	981	O75122
DAQPAARSMDSDSGE	TNFAIP8L3	81	Q5GJ75
MAAKSDGAAASASPD	XKR7	1	Q5GH72
ANDSSRAPSSGMDAS	SLC5A5	501	Q92911
RNSSLSMAPDSSGSS	ZC2HC1C	366	Q53FD0
DNRAGMTSSPDATTG	ZNF148	776	Q9UQR1
LQGTASSNASAPDAM	LMF1	421	Q96S06